MedPath

Bone Morphogenetic Protein-2 Levels in GFF after Hydroxyapatite Tricalcium Phosphate Bone Graft in Vertical Defect, A RCT

Phase 4
Conditions
Periodontitis patient with vertical bone defect and systemically healthy
Registration Number
JPRN-UMIN000053980
Lead Sponsor
Indonesian Agency for the Assessment and Application of Technology and Dental Faculty Universitas Padjadjaran, Indonesia
Brief Summary

There was an increase in BMP-2 levels in the treatment group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion patients included patients diagnosed with aggressive periodontitis, pregnant and lactating women, wearing orthodontic appliances, taking antibiotics, anti-inflammatory and immunosuppressants for the last three months, and having a history of uncontrolled systemic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath